Publicaciones en las que colabora con Manuel de la Mata García (31)

2024

  1. Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure

    Digestive and Liver Disease, Vol. 56, Núm. 10, pp. 1721-1729

  2. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis

    JHEP Reports, Vol. 6, Núm. 2

  3. Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements

    Hepatology, Vol. 79, Núm. 4, pp. 869-881

  4. Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis

    Hepatology, Vol. 79, Núm. 3, pp. 624-635

  5. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding

    Journal of Hepatology, Vol. 80, Núm. 1, pp. 73-81

2023

  1. Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode

    Liver International, Vol. 43, Núm. 7, pp. 1548-1557

2022

  1. Reply to: “Potential novel approaches to prevent the risk of infection in patients with variceal bleeding”

    Journal of Hepatology

2021

  1. A simple nomogram identifies patients with refractory ascites with worse outcome after transjugular intrahepatic portosystemic shunt

    European journal of gastroenterology & hepatology, Vol. 33, Núm. 1S Suppl 1, pp. e587-e593

  2. Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis

    Journal of Hepatology, Vol. 75, Núm. 2, pp. 342-350

  3. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data

    Gastroenterology, Vol. 160, Núm. 1, pp. 193-205.e10

  4. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108

2020

  1. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension

    Journal of Hepatology, Vol. 73, Núm. 6, pp. 1415-1424

  2. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites

    Journal of Hepatology, Vol. 73, Núm. 6, pp. 1404-1414

  3. Persistence of clinically significant portal hypertension after eradication of hepatitis C virus in patients with advanced cirrhosis

    Clinical Infectious Diseases, Vol. 71, Núm. 10, pp. 2726-2729

  4. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients

    Liver International, Vol. 40, Núm. 9, pp. 2215-2227

  5. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

    Journal of Hepatology, Vol. 73, Núm. 5, pp. 1082-1091

  6. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Journal of Hepatology, Vol. 73, Núm. 4, pp. 842-854

  7. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis

    Journal of Hepatology, Vol. 72, Núm. 6, pp. 1140-1150

2019

  1. Gastrointestinal bleeding following transduodenal endoscopic ultrasound-guided gallbladder drainage

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 6, pp. 376-377

  2. The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery

    Journal of Hepatology, Vol. 71, Núm. 5, pp. 942-950